Ye Jin Kim1,†, Chaeyoung Lee1,†, Soo Kyung Seo1, Jae Won Roh1, Hye Ryung Lee1, Su Jin Hwang2, Nienping Chang3, Hee Seong Choi3, Dong Hoon Shin1, Hui Kwon Kim4, Han Sang Kim5, Hyun-Soo Cho3, Jae Myun Lee2, Heon Yung Gee1, Min Goo Lee1,6* and Shin Hye Noh1,6*
1Department of Pharmacology, Brain Korea 21 Project for Medical Science, Woo Choo Lee Institute for Precision Drug Development, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
2Department of Microbiology and Immunology, Institute for Immunology and Immunological Diseases, Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
3Department of Systems Biology and Division of Life Sciences, Yonsei University, Seoul 03722, Republic of Korea.
4Department of Integrative Biotechnology, Sungkyunkwan University, Suwon 16419, Republic of Korea.
5Division of Medical Oncology, Departments of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul 03722, Republic of Korea
6Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
†These authors contributed equally to this work.
*Corresponding authors: Min Goo Lee and Shin Hye Noh